An Open Study to Evaluate the Sustained Effect in Patients Showing Virological Responses With Muscle-related Symptom of Chronic Hepatitis B Patients Who Received Clevudine.
Phase of Trial: Phase IV
Latest Information Update: 25 Jul 2012
At a glance
- Drugs Clevudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Bukwang Pharmaceutical
- 25 Jul 2012 Actual end date (Apr 2012) added as reported by ClinicalTrials.gov.
- 25 Dec 2010 New trial record